John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Lizzy Lawrence leads STAT’s ...

Novo Nordisk is leaning on clinical evidence, localised pricing and partnerships as its frontline defence in India’s brutal semaglutide price war unleashed after the Danish company’s patent expired on ...

India's pharma industry is ready to flex its generics muscle as the patent for a key ingredient of blockbuster weight-loss drugs expires today. Pharmarack estimates India’s weight-loss drug market to ...

At least a dozen large drugmakers are set to roll out copies of Novo Nordisk’s blockbuster weight-loss drugs in India, crashing prices as soon as the patent expires on Friday. Natco Pharma plans to ...

Did our AI summary help? Health activists and clinicians have sounded alarm over an “aggressive” promotional blitz, as dozens of affordable generic weight-loss therapies are set to enter Indian market ...

When Bonnie Evoy entered her mid-60s, she unexpectedly and rapidly gained weight. She tried for two years to lose it, working out almost daily, even when sick or injured, and trying all sorts of diets ...

Deutsch joined Drexel from Kingsborough Community College-CUNY, where he served as professor and founding director of the culinary arts program as well as deputy chair of the department of tourism and ...

The FDA has approved a generic version of fluticasone propionate (marketed as Flovent HFA), according to a statement issued on March 3. The approval extends the accessibility of the medication, ...

A newly-formed Canadian pharmaceutical company is vying to break into the market with a generic version of one of the most well-known prescription drugs in the world: Ozempic. “You could say we’re ...

Muriel, from the Auxiliary of Social Life, works at the home of Mr. T, who has multiple sclerosis, in Pas de Calais, France, on June 11, 2023. (Astier / BSIP via AFP) (CN) — For people living with ...